Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

IMM-20059

Product Specifications

Bioactivity

IMM-20059 is a humanized IgG1 monoclonal antibody targeting EPN1. When combined with Atezolizumab, IMM-20059 significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Thalidomide-CH2NH2 (hydrochloride)
HY-44249-01 5 mg

Thalidomide-CH2NH2 (hydrochloride)

Sign In for Pricing
View Details
Thalidomide-CH2NH2 (hydrochloride)
HY-44249-02 10 mg

Thalidomide-CH2NH2 (hydrochloride)

Sign In for Pricing
View Details
Thalidomide-CH2NH2 (hydrochloride)
HY-44249-03 25 mg

Thalidomide-CH2NH2 (hydrochloride)

Sign In for Pricing
View Details
Thalidomide-CH2NH2 (hydrochloride)
HY-44249-04 50 mg

Thalidomide-CH2NH2 (hydrochloride)

Sign In for Pricing
View Details
Thalidomide-CH2NH2 (hydrochloride)
HY-44249-05 100 mg

Thalidomide-CH2NH2 (hydrochloride)

Sign In for Pricing
View Details
Lentiviral human SLC25A36 shRNA (UAS) - Lentiviral human SLC25A36 shRNA (UAS, GFP) (100)
GTR15161373 1 Vial

Lentiviral human SLC25A36 shRNA (UAS) - Lentiviral human SLC25A36 shRNA (UAS, GFP) (100)

Sign In for Pricing
View Details